Edmund Ingham Profile - Forbes Blogger
123 Followers
Edmund Ingham's Stock Coverage
| BEAMBeam Therapeutics | Nov 12, 2026 | Bullish | 2Ratings | -32.00% | ||
| WVEWave Life Sciences | Nov 10, 2026 | Neutral | 2Ratings | -9.60% | ||
| DFTXDefinium Therapeutics | Nov 10, 2026 | Neutral | 2Ratings | -56.80% | ||
| IONSIonis Pharmaceuticals | Nov 09, 2026 | Neutral | 8Ratings | +33.08% | ||
| IOVAIovance Biotherapeutics | Nov 06, 2026 | Bullish | 11Ratings | +109.18% | ||
| RVMDRevolution Medicines | Nov 05, 2026 | Neutral | 2Ratings | +62.60% | ||
| MDGLMadrigal Pharmaceuticals | Nov 04, 2026 | Bullish | 4Ratings | +2.63% | ||
| BCRXBioCryst | Nov 04, 2026 | Neutral | 3Ratings | -47.10% | ||
| GILDGilead Sciences | Oct 30, 2026 | Neutral | 7Ratings | +13.13% | ||
| ARDXArdelyx | Oct 30, 2026 | Neutral | 1Ratings | ― | ― |
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site. See how TipRanks ranks experts and calculates performance.